These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22981388)
21. Intraarterial chemotherapy of head and neck cancer: worth another look? Muggia FM; Wolf GT Cancer Clin Trials; 1980; 3(4):375-9. PubMed ID: 7428141 [TBL] [Abstract][Full Text] [Related]
22. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck]. Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228 [No Abstract] [Full Text] [Related]
23. Controversies surrounding the use of neoadjuvant chemotherapy in locally advanced head and neck cancer. Giralt J; Benavente S Expert Rev Anticancer Ther; 2008 Sep; 8(9):1359-63. PubMed ID: 18759687 [No Abstract] [Full Text] [Related]
24. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Murdoch D Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639 [TBL] [Abstract][Full Text] [Related]
25. Concurrent radio-chemotherapy combination in patients with advanced head and neck squamous cell carcinoma. Bourhis J Onkologie; 2005 Oct; 28(10):473-4. PubMed ID: 16285033 [No Abstract] [Full Text] [Related]
26. Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium. Hainsworth JD; Spigel DR; Greco FA; Shipley DL; Peyton J; Rubin M; Stipanov M; Meluch A Cancer J; 2011; 17(5):267-72. PubMed ID: 21952273 [TBL] [Abstract][Full Text] [Related]
27. Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Jeremić B; Miličić B Am J Clin Oncol; 2009 Oct; 32(5):483-7. PubMed ID: 19506455 [TBL] [Abstract][Full Text] [Related]
28. Target volume delineation after induction chemotherapy in locally advanced head and neck cancer. De Felice F; Musio D; Tombolini V Oral Oncol; 2015 Nov; 51(11):e81. PubMed ID: 26387077 [No Abstract] [Full Text] [Related]
29. A new look at induction chemotherapy in locally advanced head and neck cancer. Vermorken JB Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881 [No Abstract] [Full Text] [Related]
30. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Sher DJ; Posner MR; Tishler RB; Sarlis NJ; Haddad RI; Holupka EJ; Devlin PM Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e813-8. PubMed ID: 21300455 [TBL] [Abstract][Full Text] [Related]
31. Integrating novel agents into the curative treatment of head and neck cancer. Haddad R; Allen A; Wirth L; Tishler R; Posner M Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367 [No Abstract] [Full Text] [Related]
32. Combination treatment in advanced head and neck cancer. Clifford P; O'Connor AD; Carter RL; Dalley VM; Darby AJ; Deutsch G; Durden-Smith DJ; Edwards WG; Grant H; McGuire NG; Peto J Lancet; 1982 Sep; 2(8300):708-9. PubMed ID: 6126639 [No Abstract] [Full Text] [Related]
33. Chemotherapy in head and neck cancer. Hong WK; Bromer R N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588 [No Abstract] [Full Text] [Related]
34. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck. Le Tourneau C; Siu LL Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623 [TBL] [Abstract][Full Text] [Related]
35. Development of targeted therapy for squamous cell carcinomas of the head and neck. Burgos-Tiburcio A; Santos ES; Arango BA; Raez LE Expert Rev Anticancer Ther; 2011 Mar; 11(3):373-86. PubMed ID: 21417852 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for squamous cell carcinoma of the head and neck: an overview. Espinola TE; White JA J La State Med Soc; 1990 Jul; 142(7):15-8. PubMed ID: 2204670 [TBL] [Abstract][Full Text] [Related]
37. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546 [TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of squamous cell carcinoma of the head and neck. Greenberg BR Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534 [No Abstract] [Full Text] [Related]
39. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of low-dose cisplatin-based chemo-irradiation in assessing hearing loss for locally advanced head and neck cancer. Liao XB; Yan SX Radiother Oncol; 2009 Feb; 90(2):282, author reply 282-3. PubMed ID: 19042049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]